My Web Dashboard





MSN News: FDA Approves Oral Contraceptive YAZ For Treatment Of Premenstrual Dysphoric Disorder (Medical News Today)

Schering subsidiary Berlex on Thursday announced that FDA has approved its oral contraceptive pill YAZ to treat premenstrual dysphoric disorder, a severe form of premenstrual syndrome, the AP/MSN Money reports (AP/MSN Money, 10/5). YAZ contains ethinyl estradiol and drospirenone and is taken once a day for 24 days followed by four days of placebo to induce a menstrual period. [click link for full

read more...

Related News